Learn how to properly report serious adverse events from generic drugs. Understand why these reactions are underreported, how to identify the manufacturer, and why your report matters for patient safety.
Learn how to verify if your medication is real using official tools like the EU's FMD system, FDA resources, QR codes, and more. Protect yourself from dangerous counterfeit drugs.
Understanding how medication safety science identifies real-world drug risks beyond clinical trials, using data, statistics, and patient outcomes to protect lives and improve prescribing.
Clinicians are raising alarms about the quality of generic drugs made overseas, citing higher rates of adverse events and unreliable manufacturing. Here's what's really happening behind the labels.
Learn how to verify your prescription at the pharmacy with a simple 6-step checklist to avoid dangerous medication errors. Know what to check, what to ask, and how to protect yourself.
Dangerous medical abbreviations like QD, U, and MS cause preventable errors that harm patients. Learn which ones to avoid, why they’re risky, and how to stop them from costing lives.
Understand the FDA's three-tier system for manufacturing changes in pharmaceuticals: major, moderate, and minor. Learn what triggers approval, notification, and annual reporting - and how to avoid costly regulatory mistakes.
Euglycemic DKA is a dangerous form of diabetic ketoacidosis that occurs with normal blood sugar levels, often in patients taking SGLT2 inhibitors like Farxiga or Jardiance. It's easily missed but can be fatal without prompt recognition and treatment.
China and India dominate global pharmaceutical manufacturing, but FDA monitoring reveals stark differences in compliance. India leads in regulatory reliability, while China offers scale at higher risk. Here's what you need to know about drug safety and supply chain risks.
Learn how to spot fake medication packaging and seals with simple, practical checks anyone can do. From color mismatches to QR code scams, this guide helps you protect yourself from dangerous counterfeit drugs.
States are using MAC lists, mandatory substitution, and price gouging laws to control Medicaid generic drug costs. With generics making up 85% of prescriptions but only 16% of spending, these policies save billions - but supply chain risks and PBM opacity threaten their success.
Health plans use tiered formularies, mandatory substitution, and step therapy to steer patients toward generic drugs, saving billions annually. But hidden pricing practices by pharmacy benefit managers often prevent patients from seeing the full savings.